Who To Watch In Health Care Policy Under Trump
From Newt Gingrich to President Barack Obama, speculation about who will be the central figures to watch in US health care policy in the Trump administration occupied panelists at the Partnering for Cures meeting.
You may also be interested in...
Obama administration wasn’t bad but had ‘less than thrilling moments,’ BIO exec says; former FDA Commissioner says leadership, not scientific, skill is key attribute for next agency chief.
A posting on the transition website takes a much milder tone than the GOP platform issued over the summer.
Wall Street has made up its mind that the Nov. 8 US elections were great for biopharma companies. But is it really that clear cut?